Bohai makes drugs mainly from organic and natural ingredients such as herbs and honey that the bulk of China’s 1.4 billion people use to treat common ailments like back pain, asthma and influenza. Its stock now trades — very quietly — in the U.S.
Continue reading Inside Wall Street: A Traditional Chinese Medicine Maker Beckons U.S. Investors
Inside Wall Street: A Traditional Chinese Medicine Maker Beckons U.S. Investors originally appeared on DailyFinance on Mon, 20 Sep 2010 14:30:00.
Filed Under: Company News, Columns, Investing, Health Care, Stock Picks